Murine knockin model for progranulin-deficient frontotemporal dementia with nonsense-mediated mRNA decay
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Significance: Mutations in the GRN gene cause frontotemporal dementia, a devastating neurological disease. The majority of these GRN mutations are nonsense and frameshift mutations. Here, we generated a knockin mouse model with a Grn mutation corresponding to the most prevalent human disease mutation, GRN R493X . We show that mice harboring this mutation phenocopy progranulin-deficient mice, and that the mutation triggers mRNA decay and, as a consequence, low production of Grn . However, the truncated mutant protein that would be produced from this allele is functional, suggesting inhibiting mRNA decay as a therapeutic approach for individuals with progranulin-deficient frontotemporal dementia caused by nonsense mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., et al. (2006) · Nature · doi:10.1038/nature05016 · Cited by 2,058
Cruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., Rademakers, R., Vandenberghe, R., Dermaut, B., Martin, J.-J., et al. (2006) · Nature · doi:10.1038/nature05017 · Cited by 1,512
Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics
Maquat, L. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1310 · Cited by 1,214 · cited 1×
“Because of introduction of a PTC, the mutant mRNA transcribed from this allele could be a target of the nonsensemediated mRNA decay pathway (NMD) (37).”
BackgroundBang, J., Spina, S., & Miller, B. L. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00461-4 · Cited by 1,144
Self-citationKordasiewicz, H. B., Stanek, L. M., Wancewicz, E. V., Mazur, C., McAlonis, M. M., Pytel, K. A., Artates, J. W., Weiss, A., Cheng, S. H., Shihabuddin, L. S., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.05.009 · Cited by 770 · cited 1×
“Indeed, ASO-based approaches have been efficacious in mouse models of neurodegenerative diseases, including Alzheimer’s disease (69), amyotrophic lateral sclerosis (70), spinocerebellar ataxia type 2 (71), and Huntington’s disease (72).”
BackgroundTang, W., Lu, Y., Tian, Q.-Y., Zhang, Y., Guo, F.-J., Liu, G.-Y., Syed, N. M., Lai, Y., Lin, E. A., Kong, L., et al. (2011) · Science · doi:10.1126/science.1199214 · Cited by 761
Lui, H., Zhang, J., Makinson, S. R., Cahill, M. K., Kelley, K. W., Huang, H.-Y., Shang, Y., Oldham, M. C., Martens, L. H., Gao, F., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.001 · Cited by 729 · cited 5×
“Recent studies in mice also indicate increases in complement activation and altered synaptic pruning may be important pathogenic factors (22).”
BackgroundMethodInfluentialSelf-citationDeVos, S. L., Miller, R. L., Schoch, K. M., Holmes, B. B., Kebodeaux, C. S., Wegener, A. J., Chen, G., Shen, T., Tran, H., Nichols, B., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aag0481 · Cited by 516 · cited 1×
“Indeed, ASO-based approaches have been efficacious in mouse models of neurodegenerative diseases, including Alzheimer’s disease (69), amyotrophic lateral sclerosis (70), spinocerebellar ataxia type 2 (71), and Huntington’s disease (72).”
BackgroundStrikingly Different Clinicopathological Phenotypes Determined by Progranulin-Mutation Dosage
Smith, K. R., Damiano, J., Franceschetti, S., Carpenter, S., Canafoglia, L., Morbin, M., Rossi, G., Pareyson, D., Mole, S. E., Staropoli, J. F., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.04.021 · Cited by 489 · cited 5×
“Homozygous knockout models display microglial activation in the CNS (19, 22, 28–31) and recapitulate NCL with lysosomal defects reflected in altered lysosome morphology (14, 29), accumulation of lipofuscin (28–30), and increased expression of lysosomal genes (23).”
BackgroundInfluentialExaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice
Yin, F., Banerjee, R., Thomas, B., Zhou, P., Qian, L., Jia, T., Ma, X., Ma, Y., Iadecola, C., Beal, M. F., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091568 · Cited by 480 · cited 4×
“Progranulin knockout (Grn) mice were generated by several laboratories, including ours (19, 21, 27, 28), and recapitulate some key features of FTD, such as neuroinflammation and behavioral changes.”
BackgroundMethodInfluentialSelf-citationYamashita, A., Ohnishi, T., Kashima, I., Taya, Y., & Ohno, S. (2001) · Genes & Development · doi:10.1101/gad.913001 · Cited by 420
Antisense oligonucleotide therapy for spinocerebellar ataxia type 2
Scoles, D. R., Meera, P., Schneider, M. D., Paul, S., Dansithong, W., Figueroa, K. P., Hung, G., Rigo, F., Bennett, C. F., Otis, T. S., et al. (2017) · Nature · doi:10.1038/nature22044 · Cited by 319
Self-citationProgranulin protects against amyloid β deposition and toxicity in Alzheimer's disease mouse models
Minami, S. S., Min, S.-W., Krabbe, G., Wang, C., Zhou, Y., Asgarov, R., Li, Y., Martens, L. H., Elia, L. P., Ward, M. E., et al. (2014) · Nature Medicine · doi:10.1038/nm.3672 · Cited by 237 · cited 1×
“An in-house sandwich ELISA for mouse progranulin was performed as described previously (21, 43).”
MethodSelf-citationYu, C.-E., Bird, T. D., Bekris, L. M., Montine, T. J., Leverenz, J. B., Steinbart, E., Galloway, N. M., Feldman, H., Woltjer, R., Miller, C. A., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.328 · Cited by 190
Self-citationYin, F., Dumont, M., Banerjee, R., Ma, Y., Li, H., Lin, M. T., Beal, M. F., Nathan, C., Thomas, B., & Ding, A. (2010) · The FASEB Journal · doi:10.1096/fj.10-161471 · Cited by 180
Almeida, S., Zhang, Z., Coppola, G., Mao, W., Futai, K., Karydas, A., Geschwind, M. D., Tartaglia, M. C., Gao, F., Gianni, D., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.007 · Cited by 140
Self-citationCore features of frontotemporal dementia recapitulated in progranulin knockout mice
Ghoshal, N., Dearborn, J. T., Wozniak, D. F., & Cairns, N. J. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.08.029 · Cited by 127
Genetic and Clinical Features of Progranulin-Associated Frontotemporal Lobar Degeneration
Chen-Plotkin, A. S., Martinez-Lage, M., Sleiman, P. M. A., Hu, W., Greene, R., Wood, E. M., Bing, S., Grossman, M., Schellenberg, G. D., Hatanpaa, K. J., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.53 · Cited by 120 · cited 3×
“We used gene targeting in murine embryonic stem cells to generate mice harboring a Grn R504X nonsense mutation analogous to human R493X, the most common GRN mutation found in individuals with FTD (3, 4, 33) (Fig.”
BackgroundMethodSelf-citationProsaposin is a regulator of progranulin levels and oligomerization
Nicholson, A. M., Finch, N. A., Almeida, M., Perkerson, R. B., van Blitterswijk, M., Wojtas, A., Cenik, B., Rotondo, S., Inskeep, V., Almasy, L., et al. (2016) · Nature Communications · doi:10.1038/ncomms11992 · Cited by 91 · cited 1×
“Primary antibodies used for immunoblot analysis include an antimouse progranulin polyclonal antibody that recognizes an epitope between amino acids 198 and 214 (79), an anti-human progranulin polyclonal antibody (NBP1-87324; Novus Biologicals) that recognizes an epitope in amino acids 140–285, an anti-mouse apoB polyc…”
BackgroundSelf-citationZhou, X., Sullivan, P. M., Sun, L., & Hu, F. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14110 · Cited by 44
Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD
Feneberg, E., Steinacker, P., Volk, A. E., Weishaupt, J. H., Wollmer, M. A., Boxer, A., Tumani, H., Ludolph, A. C., & Otto, M. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-015-1486-1 · Cited by 36 · cited 1×
“Progranulin is also secreted from cells and detectable in cerebrospinal fluid (25, 26) and blood (21, 26).”
Background
Cited by
Logan, T., Simon, M. J., Rana, A., Cherf, G. M., Srivastava, A., Davis, S. S., Low, R. L. Y., Chiu, C.-L., Fang, M., Huang, F., et al. (2021) · Cell · doi:10.1016/j.cell.2021.08.002 · Cited by 233
Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imaging
Mazur, C., Powers, B., Zasadny, K., Sullivan, J. M., Dimant, H., Kamme, F., Hesterman, J., Matson, J., Oestergaard, M., Seaman, M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.129240 · Cited by 114
Deficiency of the frontotemporal dementia gene GRN results in gangliosidosis
Boland, S., Swarup, S., Ambaw, Y. A., Malia, P. C., Richards, R. C., Fischer, A. W., Singh, S., Aggarwal, G., Spina, S., Nana, A. L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33500-9 · Cited by 97
Self-citationTFEB Transcriptional Responses Reveal Negative Feedback by BHLHE40 and BHLHE41
Carey, K. L., Paulus, G. L. C., Wang, L., Balce, D. R., Luo, J. W., Bergman, P., Ferder, I. C., Kong, L., Renaud, N., Singh, S., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108371 · Cited by 55
“In addition, we identified upregulation of innate immune response genes, including C1S and C3 complement components; CD68, a lysosomal/endosomal-associated transmembrane and lectin binding protein; and GRN, which has reported roles in signaling and inflammatory response (Nguyen et al., 2018; Sorbara et al., 2018; Tana…”
BackgroundMarsan, E., Velmeshev, D., Ramsey, A., Patel, R. K., Zhang, J., Koontz, M., Andrews, M. G., de Majo, M., Mora, C., Blumenfeld, J., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci164919 · Cited by 45
“We chose 19-month-old mice because this was close to the median survival of Grn–/– mice (4, 5).”
BackgroundMethodSelf-citation
Metadata
- Authors
- Nguyen, A. D., Nguyen, T. A., Zhang, J., Devireddy, S., Zhou, P., Karydas, A. M., Xu, X., Miller, B. L., Rigo, F., Ferguson, S. M., Huang, E. J., Walther, T. C., & Farese, R. V.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2018-03-06
- Volume
- 115
- Issue
- 12
- Pages
- E2849-E2858
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2792064886
- Cited by
- 74
- References
- 21
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.